<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Avicenna Journal of Neuropsychophysiology</title>
<title_fa>1</title_fa>
<short_title>Avicenna J Neuro Psycho Physiology</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ajnpp.umsha.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2383-2436</journal_id_issn>
<journal_id_issn_online>2383-2444</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.53208/ajnpp</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2016</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>3</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effects of Magnesium Oxide Nanoparticles on Depression- Like Behavior Induced by Naloxone and Morphine Withdrawal</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Special</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;aside style=&quot;box-sizing: border-box; font-family: Lato, Arial; word-wrap: break-word; margin-bottom: 10px; font-size: 11px;&quot;&gt;
&lt;p style=&quot;box-sizing: border-box; word-wrap: break-word; margin: 0px 0px 10px; font-size: 12px; text-align: justify;&quot;&gt;&lt;span style=&quot;box-sizing: border-box; word-wrap: break-word; font-weight: 700;&quot;&gt;Background:&lt;/span&gt;&amp;nbsp;Our previous studies indicated that nanoparticles of magnesium oxide (nano-MgO) can affect some of morphine withdrawal signs such as anxiety, but their interaction with opioidergic system activity in depression- like behavior induced by morphine withdrawal is not clear.&lt;/p&gt;
&lt;/aside&gt;

&lt;aside style=&quot;box-sizing: border-box; font-family: Lato, Arial; word-wrap: break-word; margin-bottom: 10px; font-size: 11px;&quot;&gt;
&lt;p style=&quot;box-sizing: border-box; word-wrap: break-word; margin: 0px 0px 10px; font-size: 12px; text-align: justify;&quot;&gt;&lt;span style=&quot;box-sizing: border-box; word-wrap: break-word; font-weight: 700;&quot;&gt;Objectives:&lt;/span&gt;&amp;nbsp;The present study aimed at investigating the effects of nano-MgO on depression induced by naloxone and morphine withdrawal in animals.&lt;/p&gt;
&lt;/aside&gt;

&lt;aside style=&quot;box-sizing: border-box; font-family: Lato, Arial; word-wrap: break-word; margin-bottom: 10px; font-size: 11px;&quot;&gt;
&lt;p style=&quot;box-sizing: border-box; word-wrap: break-word; margin: 0px 0px 10px; font-size: 12px; text-align: justify;&quot;&gt;&lt;span style=&quot;box-sizing: border-box; word-wrap: break-word; font-weight: 700;&quot;&gt;Methods:&lt;/span&gt;&amp;nbsp;Adult male NMRI mice were divided in 2 main groups. For the control group, intraperitoneal (i.p.) injection of nano-MgO (1, 2.5 and 5 mg/kg) or naloxone (3 and 5 mg/kg) and coinjections of naolxone5 before and after nano-MgO2.5 mg/kg were done. The morphine withdrawal group received saline or nano-MgO 2.5, 5 and 10 mg/kg as acute (a single injection at the test day) and chronic injection (coinjected with morphine for 4 days). To develop morphine dependency, increasing doses of 20, 40, and 80 mg/kg morphine were injected subcutaneously for 4 days. Then, mice received a final morphine injection (40mg/kg) 3 hours prior to naloxone (5 mg/kg (i.p.)) on the test day. Depression- like behavior was assessed by the tail suspension test.&lt;/p&gt;
&lt;/aside&gt;

&lt;aside style=&quot;box-sizing: border-box; font-family: Lato, Arial; word-wrap: break-word; margin-bottom: 10px; font-size: 11px;&quot;&gt;
&lt;p style=&quot;box-sizing: border-box; word-wrap: break-word; margin: 0px 0px 10px; font-size: 12px; text-align: justify;&quot;&gt;&lt;span style=&quot;box-sizing: border-box; word-wrap: break-word; font-weight: 700;&quot;&gt;Results:&lt;/span&gt;&amp;nbsp;Naloxone 3 and 5mg/kg induced depression (P &lt; 0.05 and P &lt; 0.01, respectively), while acute injection of nano-MgO2.5mg/kg after naloxone5 mg/kg improved depression (P &lt; 0.01). Morphine withdrawal has induced depression in addicted mice (P &lt; 0.05), while acute injection of nano-MgO2.5 mg/kg (P &lt; 0.05) and nano-MgO 5 and 10 mg/kg (P &lt; 0.01) reduced it.&lt;/p&gt;
&lt;/aside&gt;

&lt;aside style=&quot;box-sizing: border-box; font-family: Lato, Arial; word-wrap: break-word; margin-bottom: 10px; font-size: 11px;&quot;&gt;
&lt;p style=&quot;box-sizing: border-box; word-wrap: break-word; margin: 0px 0px 10px; font-size: 12px; text-align: justify;&quot;&gt;&lt;span style=&quot;box-sizing: border-box; word-wrap: break-word; font-weight: 700;&quot;&gt;Conclusions:&lt;/span&gt;&amp;nbsp;Nano-MgO can reduce depression- like behavior induced by naloxone and morphine withdrawal in animals probably by interaction with opioid receptors.&lt;/p&gt;
&lt;/aside&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Depression, Naloxone, Nanoparticles, MgO, Morphine Withdrawal</keyword>
	<start_page>119</start_page>
	<end_page>124</end_page>
	<web_url>http://ajnpp.umsha.ac.ir/browse.php?a_code=A-10-2-63&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mahnaz</first_name>
	<middle_name></middle_name>
	<last_name>Kesmati</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600292</code>
	<orcid>1003194753284600292</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Professor of Physiology, Department of Biology, Faculty of Sciences, Shahid Chamran University of Ahvaz, IR Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mozhgan</first_name>
	<middle_name></middle_name>
	<last_name>Torabi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email> mozhgan.torabii@yahoo.com</email>
	<code>1003194753284600293</code>
	<orcid>1003194753284600293</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>PhD Student of Animal Physiology, Department of Biology, Faculty of Sciences, Shahid Chamran University of Ahvaz, IR Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Konani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600294</code>
	<orcid>1003194753284600294</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Master Student of Animal Physiology, Department of Biology, Faculty of Sciences, Shahid Chamran University of Ahvaz, IR Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
